Drug intelligence / Profile preview

11C-metomidate

Development stage
Unknown
Lead developer
Uppsala University
Modality
Alpha Emitters → Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta Emitters → Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
Administration
Intravenous
01

Overview

11C-metomidate is a radiopharmaceutical PET (Positron Emission Tomography) imaging agent specifically designed for the visualization and characterization of adrenocortical tissue. It is a carbon-11 labeled analogue of metomidate, the methyl ester of the anesthetic etomidate. The drug acts as a high-affinity ligand for the cytochrome P450 enzymes **11β-hydroxylase (CYP11B1)** and **aldosterone synthase (CYP11B2)**, which are primarily expressed in the adrenal cortex. By binding to these enzymes, 11C-metomidate allows for the non-invasive detection of adrenocortical tumors, such as adenomas and carcinomas, and is particularly useful in the clinical workup of primary aldosteronism (Conn's syndrome) to lateralize aldosterone-producing lesions. It serves as a functional imaging tool to distinguish adrenocortical lesions from non-cortical adrenal masses.

Other names
[11C]metomidateCarbon-11 metomidateCarbon11 metomidateCarbon 11 metomidate11C-labeled metomidate
02

Targets

CYP11B2 (Cytochrome P450 11B2)

Beyond the preview

Go deeper on 11C-metomidate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 11C-metomidate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call